Literature DB >> 21308500

Renal Transplantation in HIV-Positive Recipients.

Jayme E Locke1, Dorry L Segev.   

Abstract

About 1% of all patients with end-stage renal disease in the United States are infected with HIV. With the introduction of highly active antiretroviral therapy (HAART), HIV death rates have declined 80%, and chronic diseases resulting from HIV have replaced opportunistic infections as the leading cause of death among HIV-infected patients. Traditionally, HIV infection has been considered an absolute contraindication to solid-organ transplantation. However, in the context of improved survival, the role for kidney transplantation among HIV-positive patients is currently being revisited. This article discusses long-term outcomes after kidney transplantation in the HAART era and management strategies for the HIV-positive kidney transplant recipient.

Entities:  

Year:  2010        PMID: 21308500     DOI: 10.1007/s11908-009-0078-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  41 in total

1.  Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

Authors:  J A Winston; L A Bruggeman; M D Ross; J Jacobson; L Ross; V D D'Agati; P E Klotman; M E Klotman
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

2.  Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999.

Authors:  Richard M Selik; Robert H Byers; Mark S Dworkin
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-01       Impact factor: 3.731

3.  Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

Authors:  A Karpas; M Lowdell; S K Jacobson; F Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 4.  Kidney transplantation in HIV-infected patients.

Authors:  Christina M Wyatt; Barbara Murphy
Journal:  Semin Dial       Date:  2005 Nov-Dec       Impact factor: 3.455

5.  Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

Authors:  V Shahinian; S Rajaraman; M Borucki; J Grady; W M Hollander; T S Ahuja
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

6.  Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

Authors:  Mysore S Anil Kumar; Debra R Sierka; Anna M Damask; Billie Fyfe; Robert F McAlack; Michael Heifets; Michael J Moritz; Daniel Alvarez; Aparna Kumar
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

Review 7.  Acid suppressive therapy and the effects on protease inhibitors.

Authors:  Patricia Pecora Fulco; Urvi B Vora; Gonzalo M L Bearman
Journal:  Ann Pharmacother       Date:  2006-11       Impact factor: 3.154

Review 8.  Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients.

Authors:  Mira Rho; Mark A Perazella
Journal:  Curr Drug Saf       Date:  2007-05

9.  Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus.

Authors:  Manisha Jain; Anita Chakravarti; Vikas Verma; Preena Bhalla
Journal:  Indian J Pathol Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.740

10.  Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Paul A Volberding; Diane Havlir; Daniel Bertenthal; Alan Bostrom; Ann M O'Hare
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

View more
  2 in total

Review 1.  Increasing the pool of deceased donor organs for kidney transplantation.

Authors:  Jesse D Schold; Dorry L Segev
Journal:  Nat Rev Nephrol       Date:  2012-03-27       Impact factor: 28.314

2.  Utilization of Public Health Service Increased Risk Donors Yields Equivalent Outcomes in Liver Transplantation.

Authors:  V A Fleetwood; J Lusciks; J Poirier; M Hertl; E Y Chan
Journal:  J Transplant       Date:  2016-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.